Clinical Trial Update: A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ASP1585 in chronic kidney disease patients with hyperphosphatemia not on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia
• Renal Insufficiency

Drugs mentioned

• ASP1585 (ASP1585)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Kidney Disease, Renal Insufficiency | Phase 3 | Status: COMPLETED